Cargando…
TB-02 NF-KB CANONICAL PATHWAY ACTIVATION DRIVES GLYCOLYSIS AND TUMOR PROGRESSION IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Recent genomic analyses have identified highly recurrent genetic alterations in PCNSL. However, due to the lack of clinically representative PCNSL preclinical models, the pathogenic mechanisms of these alterations remains largely unknown. Here, we established the largest panel of 12 clinically relev...
Autores principales: | Tateishi, Kensuke, Sasaki, Nobuyoshi, Kawazu, Masahito, Miyake, Yohei, Nakamura, Taishi, Yoshii, Yukie, Matsushita, Yuko, Miyake, Shigeta, Sasame, Jo, Yamanaka, Shoji, Yamamoto, Tetsuya, Wakimoto, Hiroaki, Nagane, Motoo, Ichimura, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213222/ http://dx.doi.org/10.1093/noajnl/vdz039.045 |
Ejemplares similares
-
CBMS-04 Novel xenograft model to clarify tumor progressive mechanism and therapeutic target in primary central nervous system lymphoma
por: Tateishi, Kensuke, et al.
Publicado: (2020) -
TB-04 TERT PROMOTER MUTATION AS A SUSCEPTIBLE MOLECULAR MARKER OF BCNU LOCAL THERAPY
por: Miyake, Shigeta, et al.
Publicado: (2019) -
HGG-51. PAIRED EPITHELIOID GLIOBLASTOMA PATIENT DERIVED XENOGRAFT MODELS WITH/WITHOUT MOLECULAR TARGET THERAPY
por: Sasame, Jo, et al.
Publicado: (2020) -
BT-07 PATIENT DERIVED XENOGRAFT MODELS OF EPITHELIOID GLIOBLASTOMA AND THERAPEUTIC VULNERABILITY IN MOLECULAR TARGET THERAPY
por: Sasame, Jo, et al.
Publicado: (2019) -
SPDR-01 Paired epithelioid glioblastoma patient-derived xenograft models to evaluate resistant mechanism for molecular target therapy
por: Sasame, Jo, et al.
Publicado: (2020)